Skip to content

The clinical and experimental study on the non-healing of incision infection after the treatment of tibial fracture

The clinical and experimental study on the non-healing of incision infection after the treatment of tibial fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17013402
Enrollment
Unknown
Registered
2017-11-15
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incision infection after tibial fracture

Interventions

Infection group:Anti-infection therapy

Sponsors

Gansu privince hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. the study or the ethics committee approved, the patient informed and signed the consent form; 2. treatment of tibia fracture; 3. single or multiple fracture; 4. closed or open fracture; 5. single limb injury or double limb injury; 6. assessment of clean wound after preoperative infection or unwound; 7. Complete data.;Inclusion criteria: 1. the study or the ethics committee approved, the patient informed and signed the consent form; 2. treatment of tibia fracture; 3. single or multiple fracture; 4. closed or open fracture; 5. single limb injury or double limb injury; 6. assessment of clean wound after preoperative infection or unwound; 7. Complete data.

Exclusion criteria

Exclusion criteria: 1. uncircumcised patients; 2. pathological fracture; 3. except for other internal and external fixers; 4. the subject disagrees and does not sign the informed consent book; 5. confirmed infected before the operation; 6. other serious diseases, such as cardiovascular disease, liver and kidney disease, hematopoietic system disease, endocrine disease, etc. 7. patients with surgical contraindications; 8. subject suspension and withdrawal of clinical trial participants; 9. serious illness, difficult to make effective appraiser.;Exclusion criteria: 1. uncircumcised patients; 2. pathological fracture; 3. except for other internal and external fixers; 4. the subject disagrees and does not sign the informed consent book; 5. confirmed infected before the operation; 6. other serious diseases, such as cardiovascular disease, liver and kidney disease, hematopoietic system disease, endocrine disease, etc. 7. patients with surgical contraindications; 8. subject suspension and withdrawal of clinical trial participants; 9. serious illness, difficult to make effective appraiser.

Design outcomes

Primary

MeasureTime frame
White blood cells;;White blood cells;

Countries

China

Contacts

Public ContactZhang Wenxian;Zhang Wenxian ;

Gansu privince hospital of TCM;Gansu privince hospital of TCM

doczhangwx@126.com;doczhangwx@126.com+86 15193163329;+86 15193163329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026